arrow
G

Gaurav D. Gaiha

ragon institute of mgh mit and harvard
H指数:24
被引数:4,010

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

B-Cell Depletion Relative to Tumor Necrosis Factor Inhibition Extends the Duration of Viral Shedding in COVID-19 Among Autoimmune Disease Patients: A Matched Prospective Cohort Study

在自身免疫病患者中,与肿瘤坏死因子抑制剂相比,B细胞耗竭延长了COVID-19的病毒脱落持续时间:一项匹配的前瞻性队列研究

2026-09-200
OAAI
Identification of cross-stage, cross-species malaria CD8+ T cell antigens

鉴定跨阶段、跨物种疟疾CD8+ T细胞抗原

Nature
IF48.5
2026-07-010
PRE
Expansion of stemlike HIV-specific CD8+ T cells and limited viral epitope diversity characterize durable posttreatment control of HIV

干性HIV特异性CD8+ T细胞的扩增和有限的病毒表位多样性是治疗后期持续控制HIV的特征

2026-04-220
PRE
Leveraging tissue-resident memory T cells for non-invasive immune monitoring via microneedle skin patches

利用组织驻留记忆T细胞通过微针皮肤贴片进行非侵入性免疫监测

2026-03-020
OAAI
Identification of mouse CD4+ T cell epitopes in SARS-CoV-2 BA.1 spike and nucleocapsid for use in peptide:MHCII tetramers
2024-03-110
OAAI
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency
2024-01-2427
OA
T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19
2023-11-2919
PRE
Viral and host mediators of non-suppressible HIV-1 viremia

不可抑制的HIV-1病毒血症的病毒和宿主介质

2023-11-1313
OAAI
Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide
2023-05-227
OAAI
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

泛变体mrna-lnp T细胞疫苗可保护HLA转基因小鼠在感染SARS-CoV-2 β 后免于死亡

2023-03-095
OAAI
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines

mRNA-1273,BNT162b2和ad26.cov2.s新型冠状病毒肺炎疫苗的免疫原性和有效性比较

2021-12-0994
OAAI
HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV
2021-07-0121
OAAI